In this Bioanalysis Zone interview, Graeme Dennis (IDBS) discusses the biggest emerging trends in scientific data management and what the future looks like for IDBS.
In this interview, Stephane Moreau (Shimadzu Europa) introduces the new Q-TOF LCMS-9030 instrument among other technologies available for automation and microsamping.
In this Bioanalysis Zone interview, Shane Needham (Alturas Analytics; ID, USA) discusses the advantages and disadvantages of the technologies employed by Alturas Analytics, including microflow LC–MS.
In this interview, Michael Schwenkert (Bio-Rad Laboratories) describes the challenges for development of CAR-T cell therapies that can be addressed using anti-idiotypic antibodies.
Find out more about the current research focuses at KCAS Bioanalytical & Biomarker Services and how the industry has evolved over the last 5–10 years in this interview with John Bucksath (KCAS).
Find out more about the challenges associated with CAR-T cell immunotherapies and what the future may hold for the field in this interview with Marco Ruella.
In this interview Alex Hawes (LGC; Cambridge, UK) discusses the topic of immunogenicity. She explains how she developed her first anti-drug antibody analytical method and the platforms LGC use in their immunogenicity sector.
Find out more about working with immunogenicity as well as what the future may hold for the field in this interview with Joyce Slusser (KCAS).
Dr Bonner serves as a scientific resource and technical advisor for both clients and internal…
In this feature, we follow up with our previous winners to get their tips and advice for those starting out in bioanalysis.